1-3 of 3
Clare Sun
Close
Sort by
Journal Articles

Cytotoxicity of the CD3×CD20 bispecific antibody epcoritamab in CLL is increased by concurrent BTK or BCL-2 targeting

Maissa Mhibik, Erika M. Gaglione, David Eik, John Herrick, Janet Le, Inhye E. Ahn, Christopher Chiu, Monica Wielgos-Bonvallet, Ida H. Hiemstra, Esther C. W. Breij, Jenny Chen, Edward B. Reilly, Pearlie K. Epling-Burnette, Edith Szafer-Glusman, Clare Sun, Adrian Wiestner
Journal: Blood Advances
Blood Adv (2023) 7 (15): 4089–4101.
https://doi.org/10.1182/bloodadvances.2022009517
Published: 2023
Includes: Supplemental data
Journal Articles

The immune microenvironment shapes transcriptional and genetic heterogeneity in chronic lymphocytic leukemia

Clare Sun, Yun-Ching Chen, Aina Martinez Zurita, Maria Joao Baptista, Stefania Pittaluga, Delong Liu, Daniel Rosebrock, Satyen Harish Gohil, Nakhle S. Saba, Theresa Davies-Hill, Sarah E. M. Herman, Gad Getz, Mehdi Pirooznia, Catherine J. Wu, Adrian Wiestner
Journal: Blood Advances
Blood Adv (2023) 7 (1): 145–158.
https://doi.org/10.1182/bloodadvances.2021006941
Published: 2023
Includes: Supplemental data
Journal Articles

BTK inhibitors impair humoral and cellular responses to recombinant zoster vaccine in CLL

Clinical Trials & Observations
Christopher Pleyer, Kerry J. Laing, Mir A. Ali, Christopher L. McClurkan, Susan Soto, Inhye E. Ahn, Pia Nierman, Emeline Maddux, Jennifer Lotter, Jeanine Superata, Xin Tian, Adrian Wiestner, Jeffrey I. Cohen, David M. Koelle, Clare Sun
Journal: Blood Advances
Blood Adv (2022) 6 (6): 1732–1740.
https://doi.org/10.1182/bloodadvances.2021006574
Published: 2022
Includes: Supplemental data